The Trump administration underlines a “clear shift away from harm reduction and practices” that it says facilitates illegal ...
Veradermics' hair loss pill late-stage trial success, FDA fast-tracks reviews for psychedelics, and more biotech news ...
Archelle Georgiou understands Americans’ frustrations with prior authorization. She helped squash the practice before, at ...
“Think of it like charging your phone,” Motif co-founder and CEO Jacob Robinson told STAT’s O. Rose Broderick. Read their ...
FDA approved a request from Motif Neurotech, to start an initial feasibility trial to test a brain implant to treat ...
The company is one of the most advanced players in the hair loss field, which has seen a surge of investor enthusiasm.
Intellia disclosed that a single dose of its gene editing treatment dramatically reduced swelling attacks in patients with ...
A long-acting injectable treatment for plaque psoriasis helped 63% of patients achieve complete skin clearance in a clinical ...
Fewer than half of papers published by NIH-funded researchers analyze or report their data by sex, a new study found.
The thinking about what risk Covid poses — or doesn't pose — has shifted in recent years. What does it mean for you?
As a medical student and researcher, I was shocked by the brazen inequity of the trial. Randomized controlled trials have ...
Legal agreements that directly shape access to care remain invisible to the very people whose lives they govern.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results